Biomimetic Nanovaccine Integrating Dendritic Cell Exosomes with Tumor Cell Membranes for Sustained Prophylaxis Against Glioblastoma
Advanced Functional Materials · 2026-06 · 36 (48)
DOI: 10.1002/adfm.202527324 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Functional Materials, online erschienen am 22.04.2026. Verfasst von Shanshan Li und 6 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Glioblastoma (GBM), one of the most aggressive and lethal brain tumors, remains incurable with a poor clinical prognosis. Cancer vaccines hold great potential for preventing malignant tumors, including GBM. However, conventional GBM vaccines face significant limitations, such as inefficient antigen delivery, safety concerns, and high production costs. Here, we have successfully developed a natural vaccine (DEX/GM) based on dendritic cell‐derived exosomes (DEX) coated with glioblastoma cell membranes (GM) that can efficiently stimulate systemic antitumor immune responses via enhancing antigen uptake by antigen‐presenting cells (APCs) and enabling sustained antigen release. The high density of tumor‐associated antigens on the cell membrane surface, combined with the intrinsic immunogenicity of DEX, promotes long‐term immune memory. Following an optimized three‐dose vaccination regimen, DEX/GM significantly induced cytokine expression and triggered the generation and activation of immune cells, including cytotoxic T cells, mature dendritic cells, and memory T cells. Importantly, this vaccination schedule demonstrated superior preventative GBM effects in mice, as all vaccinated mice survived up to 150 days even when challenged up to three times via intracranial injection of exponentially growing GL261‐luc GBM tumor cells. Therefore, our all‐natural tumor vaccine may offer a versatile strategy for the prevention of GBM, and potentially other malignant tumors, paving the way for promising future clinical applications.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Li, S., Zhang, D., Wang, S., Pang, C., Zheng, M., Shi, B., & Zou, Y. (2026). Biomimetic Nanovaccine Integrating Dendritic Cell Exosomes with Tumor Cell Membranes for Sustained Prophylaxis Against Glioblastoma. Advanced Functional Materials, 36(48). https://doi.org/10.1002/adfm.202527324
Vancouver
Li S, Zhang D, Wang S, Pang C, Zheng M, Shi B, et al. Biomimetic Nanovaccine Integrating Dendritic Cell Exosomes with Tumor Cell Membranes for Sustained Prophylaxis Against Glioblastoma. Advanced Functional Materials. 2026;36(48). doi:10.1002/adfm.202527324
BibTeX
@article{Li2026,
author = {Li, Shanshan and Zhang, Dongya and Wang, Shiyu and Pang, Changhe and Zheng, Meng and Shi, Bingyang and Zou, Yan},
title = {Biomimetic Nanovaccine Integrating Dendritic Cell Exosomes with Tumor Cell Membranes for Sustained Prophylaxis Against Glioblastoma},
journal = {Advanced Functional Materials},
year = {2026},
volume = {36},
number = {48},
doi = {10.1002/adfm.202527324}
}
EUVIMED